Rational development of adjunct immune-based therapies for drug-resistant tuberculosis: hypotheses and experimental designs.

@article{Zumla2012RationalDO,
  title={Rational development of adjunct immune-based therapies for drug-resistant tuberculosis: hypotheses and experimental designs.},
  author={Alimuddin I. Zumla and Markus J. Maeurer},
  journal={The Journal of infectious diseases},
  year={2012},
  volume={205 Suppl 2},
  pages={S335-9}
}
The poor treatment outcomes for extensively drug-resistant and multidrug-resistant tuberculosis and the slow progress in development and evaluation of new tuberculosis drugs gave rise to development of several potential immune-based therapies for adjunct use with drug treatment. However, none of these therapies have been shown to be of benefit in controlled… CONTINUE READING